Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
03 Apr 2019 Global Microbial Signatures Specific for Colorectal Cancer Revealed Gastrointestinal cancers
02 Apr 2019 EMA Recommends Extension of Indications for Plerixafor Cancer in Special Situations / Population
01 Apr 2019 EMA Recommends Extensions of Indication for Lenalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
29 Mar 2019 EMA Recommends Extension of Indications for Pomalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
28 Mar 2019 EU Actions to Prevent Medicine Shortages Due to Brexit Bioethics, legal and economic issues
27 Mar 2019 Glucocorticoids Promote Breast Cancer Metastases Breast cancer - Translational research
26 Mar 2019 NICE Issues Technology Appraisal Guidance for Pertuzumab Breast cancer - Personalised medicine - Anticancer agents & Biologic therapy
25 Mar 2019 NICE Issues Technology Appraisal Guidance for Brigatinib Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
21 Mar 2019 EMA Starts Review on Screening Patients Before Treatment with Fluorouracil, Capecitabine, Tegafur and Flucytosine Anticancer agents & Biologic therapy
20 Mar 2019 FDA Approves Atezolizumab for Extensive-Stage SCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
18 Mar 2019 NICE Issues Technology Appraisal Guidance on Tisagenlecleucel for Treating Relapsed or Refractory DLBCL Haematologic malignancies - Cancer Immunology and Immunotherapy
14 Mar 2019 Cancer Neoantigens: Implications for Immune Response and Cancer Immunotherapy Translational research - Cancer Immunology and Immunotherapy
13 Mar 2019 Persistent Long-term Fatigue Among Epithelial Ovarian Cancer Survivors Gynaecologic malignancies
11 Mar 2019 FDA Approves Atezolizumab for PD-L1 Positive Unresectable Locally Advanced or Metastatic TNBC Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
08 Mar 2019 NICE Issues Technology Appraisal Guidance on Encorafenib with Binimetinib Melanoma and other skin tumours - Personalised medicine - Anticancer agents & Biologic therapy